Akira Komoto

Affiliations

Patient Safety Japan, Bristol Myers Squibb K.K., Tokyo, Japan.

Publications (3)

The safety profile of nivolumab plus ipilimumab combination therapy in Japanese patients with renal cell carcinoma: results from post-marketing surveillance.

Japanese journal of clinical oncology

Avec: Hirotsugu Uemura , Nobuo Shinohara , Yoshihiko Tomita , Norio Nonomura , Takako Yamada , Ai Yoshida ,

Postmarketing surveillance of nivolumab plus ipilimumab combination therapy in Japanese patients with unresectable malignant melanoma.

The Journal of dermatology

Avec: Naoya Yamazaki , Yoshio Kiyohara , Hisashi Uhara , Tetsuya Tsuchida , Ai Yoshida , Takako Yamada ,

Real-world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance.

The Journal of dermatology

Avec: Naoya Yamazaki , Yoshio Kiyohara , Hisashi Uhara , Tetsuya Tsuchida , Keiko Maruyama , Naoki Shakunaga , Eijun Itakura ,

Réseau de co-auteurs

Takako Yamada 2 collaborations

Ai Yoshida 2 collaborations

Naoya Yamazaki 2 collaborations

Yoshio Kiyohara 2 collaborations

Hisashi Uhara 2 collaborations

Tetsuya Tsuchida 2 collaborations

Hirotsugu Uemura 1 collaboration

Nobuo Shinohara 1 collaboration

Yoshihiko Tomita 1 collaboration

Norio Nonomura 1 collaboration

Keiko Maruyama 1 collaboration

Naoki Shakunaga 1 collaboration

Eijun Itakura 1 collaboration